{"filing":{"accession_number":"0001193805-26-000645","cik":"0001280776","ticker":null,"company_name":"IMMUNIC, INC.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"e665479_8k-immunic.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000645/e665479_8k-immunic.htm"},"classifications":[{"id":214,"accession_number":"0001193805-26-000645","item_number":"5.02","item_title":"Departure of Directors or Principal Officers;","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michael W. Bonney was appointed as Chair of the Board effective May 16, 2026, a principal officer position. The disclosure details his extensive executive and board leadership experience across multiple biotechnology companies, including prior CEO roles at Cubist Pharmaceuticals and Kaleido Biosciences. This appointment of a senior board leadership position is material to investors assessing the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:22:20.885165+00:00","company_name":"IMMUNIC, INC.","ticker":null,"filing_date":"2026-05-19"},{"id":215,"accession_number":"0001193805-26-000645","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Mr. Bonney as Chair of the Board, announced via press release on May 19, 2026. This is a material executive appointment to a senior governance role. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment that would affect a reasonable investor's assessment of the company's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:22:20.885165+00:00","company_name":"IMMUNIC, INC.","ticker":null,"filing_date":"2026-05-19"}]}